Clinical Trial Update: Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating anlotinib hydrochloride in combination with epirubicin and ifosfamide for soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)
• Epirubicin (epirubicin)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: UNKNOWN